RxDoctor Payments Data

Bradley Boyd, DO

Orthopaedic Surgery · Fairfax, VANPI 1134384720

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $435,175 of the $540,145 with a category attached, or 80.6%. Stryker accounts for 95.5% of it on its own, with 18 other manufacturers making up the rest. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$540,145in general payments, 2019–2025

Across 646 payments — averaging $836.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$516K
  • Pacira Therapeutics, Inc.$23K
  • Amgen$205
  • Johnson & Johnson$185
  • Avanos Medical$140
  • Pacira Pharmaceuticals Incorporated$69
  • plus $347 from 13 others

What the payments were for

  • Consulting fees$435,17581%
  • Speaking & faculty fees$20,4944%
  • Travel & lodging$69,32113%
  • Food & beverage$15,1553%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$540,145 in reported general payments places this provider in the 95th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$765,360
Medicare patients
947
Services billed
9,289

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib114$5,050
Mupirocin289$2,229
CefuroximeCefuroxime Axetil94$1,393
Gabapentin160$1,076
Oxycodone Hcl159$727
Tramadol Hcl238$643
Dexamethasone72$509
Tizanidine Hcl17$382
Diclofenac Sodium25$334
Cephalexin19$255
Ondansetron OdtOndansetron16$213
Methylprednisolone15$125
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29$124
Zolpidem Tartrate17$100
Hydromorphone Hcl12$64

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Fairfax

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →